Penumbra (PEN) Cash from Investing Activities (QoQ) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Penumbra | 12.52 Bn | 11.91 Bn | 253.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 86.42% |
| Dec 31, 2025 | -38.55% |
| Sep 30, 2025 | -945.32% |
| Jun 30, 2025 | -3,003.59% |
| Mar 31, 2025 | 95.42% |
| Dec 31, 2024 | -130.67% |
| Sep 30, 2024 | 3.62% |
| Jun 30, 2024 | 87.52% |
| Mar 31, 2024 | -24.28% |
| Dec 31, 2023 | 154.69% |
| Sep 30, 2023 | -565.51% |
| Jun 30, 2023 | -162.28% |
| Mar 31, 2023 | 24.07% |
| Dec 31, 2022 | -11.78% |
| Sep 30, 2022 | -52.63% |
| Jun 30, 2022 | 31.50% |
| Mar 31, 2022 | 1,273.34% |
| Dec 31, 2021 | 97.31% |
| Sep 30, 2021 | -289.15% |
| Jun 30, 2021 | 752.59% |
| Mar 31, 2021 | 130.22% |
| Dec 31, 2020 | 79.31% |
| Sep 30, 2020 | 9.40% |
| Jun 30, 2020 | -643.43% |
| Mar 31, 2020 | 122.95% |
| Dec 31, 2019 | -406.24% |
| Sep 30, 2019 | 194.49% |
| Jun 30, 2019 | -147.44% |
| Mar 31, 2019 | 230.96% |
| Dec 31, 2018 | 146.62% |
| Sep 30, 2018 | -261.00% |
| Jun 30, 2018 | 686.37% |
| Mar 31, 2018 | 86.66% |
| Dec 31, 2017 | 31.17% |
| Sep 30, 2017 | 13.27% |
| Jun 30, 2017 | -175.30% |
| Mar 31, 2017 | -337.13% |
| Dec 31, 2016 | 210.02% |
| Sep 30, 2016 | -194.15% |
| Jun 30, 2016 | -181.05% |
| Mar 31, 2016 | 101.24% |
| Dec 31, 2015 | -8,923.71% |
| Sep 30, 2015 | -103.83% |
| Jun 30, 2015 | 397.06% |
| Mar 31, 2015 | 807.34% |